Johnson & Johnson (NYSE: JNJ) is dividend royalty. The healthcare behemoth has increased its dividend payment for 62 straight years. That puts it in the elite group of Dividend Kings, companies with 50 or more years of consecutive annual dividend growth. The healthcare stock also stands out for its higher dividend yield. With a nearly 3.3% forward dividend yield, an investment in J&J.
Source: FlipItMoney
Ad
Ad